Fear of Cancer Recurrence in Patients with Multiple Myeloma: Prevalence and Predictors Based on a Family Model Analysis

Overview

Journal Psychooncology

Publisher Wiley

Specialties Oncology
Psychology

Date 2020 Sep 15

PMID 32931646

Citations 16

Authors

Xiaochun Hu

Weida Wang

Ye Wang

Ke Liu

Affiliations

Soon will be listed here.

Abstract

Objective: Fear of cancer recurrence (FCR) is a common psychosocial sequela among cancer survivors, but data on patients with multiple myeloma are scarce. This study calculated the prevalence of FCR and identified family and social factors that predict FCR in the study population.

Methods: We recruited 127 myeloma patients and their partners to participate in a cross-sectional survey from a regional tertiary cancer centre in China. The questionnaires included items on demographic characteristics and from the fear of disease progression simplified scale, family hardiness index and Social Support Scale. Univariate and multivariate regression was used to identify predictors of FCR.

Results: Of the participants, 56.4% patients reported high-level FCR, which was similar to the partner-reported proportion. The partners' FCR was positively associated with the patients' FCR, while family hardiness and social support were statistically significant, negative predictors.

Conclusions: Interventions to mitigate partners' FCR and improve family hardiness and social support may help with the psychological adjustment and well-being of myeloma patients.

Citing Articles

How does family resilience develop among stroke survivors and their caregivers? A mixed-method study using a chain mediating model.

Ye Q, Yang Y, Li J, Wang T, Liu N Int J Nurs Stud Adv. 2024; 7:100246.

PMID: 39391565 PMC: 11465215. DOI: 10.1016/j.ijnsa.2024.100246.

Past Happiness and Broken Future Horizon of Oncological Patients during Chemotherapy-A Quantitative Exploration of a Phenomenological Hypothesis.

Fryze M, Wisniewska P, Wiertlewska-Bielarz J, Moskalewicz M Cancers (Basel). 2024; 16(11).

PMID: 38893243 PMC: 11171201. DOI: 10.3390/cancers16112124.

Fear of cancer recurrence in adolescent patients with malignant bone tumors: a cross-section survey.

Ye Q, Xue M, Yu Q, Ren Y, Long Y, Yao Y BMC Public Health. 2024; 24(1):1471.

PMID: 38824589 PMC: 11143769. DOI: 10.1186/s12889-024-18963-3.

Fear of cancer recurrence and associated factors in family caregivers of patients with hematologic malignancy receiving chemotherapy: A latent profile analysis.

Sheng L, Zhu Y, Liu Y, Hua H, Zhou J, Ye L Asia Pac J Oncol Nurs. 2024; 11(4):100382.

PMID: 38495640 PMC: 10940887. DOI: 10.1016/j.apjon.2024.100382.

Investigating fear of cancer recurrence among female breast cancer survivors and their spouses in southwest China: a cross-sectional study.

Tao L, Ma X, Yang Y, Hu X, Fu L, Li J BMJ Open. 2024; 14(2):e077964.

PMID: 38331853 PMC: 10860109. DOI: 10.1136/bmjopen-2023-077964.

References

Latella L, Rogers M, Leventhal H, Parker P, Horwitz S, Matasar M . Fear of cancer recurrence in lymphoma survivors: A descriptive study. J Psychosoc Oncol. 2019; 38(3):251-271. PMC: 7159999. DOI: 10.1080/07347332.2019.1677840. View

Hinz A, Mehnert A, Ernst J, Herschbach P, Schulte T . Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer. 2014; 23(6):1579-87. DOI: 10.1007/s00520-014-2516-5. View

Chumdaeng S, Soivong P, Sethabouppha H, Chontawan R . Health problems among breast cancer survivors after completing conventional treatments: A cross-sectional study. Nurs Health Sci. 2020; 22(2):436-444. DOI: 10.1111/nhs.12678. View

Mellon S, Northouse L . Family survivorship and quality of life following a cancer diagnosis. Res Nurs Health. 2001; 24(6):446-59. DOI: 10.1002/nur.10004. View

Rajkumar S, Dimopoulos M, Palumbo A, Blade J, Merlini G, Mateos M . International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15(12):e538-48. DOI: 10.1016/S1470-2045(14)70442-5. View

Esser P, Gotze H, Mehnert-Theuerkauf A, Knoop H, Kuba K . Fear of progression and its role in the relationship of cancer-related fatigue with physical functioning and global quality of life - A register-based study among hematological cancer survivors. J Psychosom Res. 2019; 127:109844. DOI: 10.1016/j.jpsychores.2019.109844. View

Mahendran R, Liu J, Kuparasundram S, Griva K . Validation of the English and simplified Mandarin versions of the Fear of Progression Questionnaire - Short Form in Chinese cancer survivors. BMC Psychol. 2020; 8(1):10. PMC: 6995061. DOI: 10.1186/s40359-020-0374-0. View

Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S . Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7(3):300-22. DOI: 10.1007/s11764-013-0272-z. View

Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S . Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005; 58(6):505-11. DOI: 10.1016/j.jpsychores.2005.02.007. View

10.

Kelly M, Dowling M . Patients' lived experience of myeloma. Nurs Stand. 2011; 25(28):38-44. DOI: 10.7748/ns2011.03.25.28.38.c8397. View

11.

Mateos M, Hernandez J, Hernandez M, Gutierrez N, Palomera L, Fuertes M . Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression. Haematologica. 2008; 93(4):560-5. DOI: 10.3324/haematol.12106. View

12.

Herschbach P, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G . Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom. 2009; 79(1):31-8. DOI: 10.1159/000254903. View

13.

Ozga M, Aghajanian C, Myers-Virtue S, McDonnell G, Jhanwar S, Hichenberg S . A systematic review of ovarian cancer and fear of recurrence. Palliat Support Care. 2015; 13(6):1771-80. PMC: 4995592. DOI: 10.1017/S1478951515000127. View

14.

Heydarnejad M, Hassanpour D, Solati D . Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci. 2011; 11(2):266-70. PMC: 3158510. View

15.

Mehnert A, Koch U, Sundermann C, Dinkel A . Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol. 2013; 52(6):1102-9. DOI: 10.3109/0284186X.2013.765063. View

16.

Hamilton J, Wu L, Austin J, Valdimarsdottir H, Basmajian K, Vu A . Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology. 2012; 22(4):911-21. PMC: 3648213. DOI: 10.1002/pon.3091. View

17.

Herr N, Williams Jr J, Benjamin S, McDuffie J . Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014; 312(1):78-84. DOI: 10.1001/jama.2014.5950. View

18.

Kim S, Kang D, Kim I, Yoon S, Kim W, Butow P . Impact of fear of cancer recurrence on survival among lymphoma patients. Psychooncology. 2019; 29(2):364-372. DOI: 10.1002/pon.5265. View

19.

Zimmermann T, Herschbach P, Wessarges M, Heinrichs N . Fear of progression in partners of chronically ill patients. Behav Med. 2011; 37(3):95-104. DOI: 10.1080/08964289.2011.605399. View

20.

Cohee A, Adams R, Johns S, Von Ah D, Zoppi K, Fife B . Long-term fear of recurrence in young breast cancer survivors and partners. Psychooncology. 2015; 26(1):22-28. PMC: 4840075. DOI: 10.1002/pon.4008. View